Objectives: To determine individual differences in the impact of illness on the change in performance of swimmers in international competitions. Methods: Subjects were members of the Australian swimming team (33 male and 39 female, aged 15-27 years). Swimmers provided a weekly seven day recall of symptoms of illness during final six weeks of preparations for international competition over a three year period. Swimmers were categorised as either ill (one or more episodes of illness) or healthy. The measure of performances was the international point score. Mean changes in points score were calculated for healthy and ill swimmers between a national championship and an international competition (,16 weeks later). Likelihoods of substantial effects of illness on an individual's true change in performance (beneficial/trivial/harmful) were estimated from means and standard deviations, assuming a smallest substantial change of 6 points. Results: Illness was reported before international performances by 38% of female and 35% of male swimmers. For female swimmers the change in performance was 23.7 (21.5) points (mean (SD)) with illness and 22.6 (19.0) points when healthy; for male swimmers the changes were 21.4 (17.5) points with illness and 5.6 (13.2) points when healthy. The likelihoods that illness had a substantial beneficial/trivial/ harmful effect on performance of an individual swimmer were 32%/31%/37% for female and 17%/31%/ 52% for male participants (90% confidence limits ,¡10% to 20%). Conclusions: Although mild illness had only a trivial mean effect on female swimmers and a small harmful mean effect on male swimmers, there were substantial chances of benefit and harm for individuals.
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I
llness is experienced by almost 90% of athletes during training for competitions at some point during a given calendar year. 1 Although various epidemiological aspects of illness (for example, frequency, incidence, prevalence, duration, severity, and type) in athletic populations have been described in the sports medicine literature, [2] [3] [4] the impact of illness on competitive performance remains uncertain. A clearer understanding of the quantitative impact of illness on athletic performance would assist the sports medicine practitioner, coach, and athlete in assessing the need for prophylaxis before competition.
In an earlier report by our research group, illness in Australian national team swimmers was associated with a trend for impaired international competitive performance. 5 The effect of illness on performance in that study was unclear, partly because we interpreted the relation between illness and performance from the single perspective of statistical significance. There may or may not have been a good chance that the true effect was substantial, and our interpretation of the outcome and recommendation to athletes and coaches might therefore be different if we had considered the practical significance of illness on performance. A more clinically oriented approach holds that the practical significance of changes and differences in performance measures of elite athletes should be considered when evaluating the true impact of illness or other intervention on performance. 6 Consideration of the practical significance overcomes concerns that results not statistically significant are often falsely discarded, yet the magnitude of the effect may well be important in athletic events where a small change in performance could mean the difference between winning and losing. 7 8 In simple terms the practical outcome of an intervention on athletic performance can be divided into three discrete categories: a worthwhile improvement, a substantial impairment, or a trivial change. Another limitation of the earlier study was a small sample size. To give more certainty about the effects of illness on performance, we have now studied clinical records and swimming performance over three consecutive years.
We also sought to examine the issue of individual responses to illness and to determine whether this effect is of similar magnitude to the mean effect. Although interpreting the individual effects of a treatment or intervention has been described in various clinical settings, 9 10 no previous study has addressed the issue of individual responses in the context of competitive sporting performance. The purpose of this study was to examine the impact of illness on competitive performance by quantifying the likelihood of a practically significant change in performance, in terms of both the mean effect in the population of elite swimmers and for an individual swimmer presenting with illness.
METHODS

Subjects
The sample was 33 male and 39 female members of the Australian swimming team (age range 15 to 29 years). In all, 133 performances (69 male and 64 female performances) were analysed over three consecutive calendar years. The international competitions during this period included the Olympic Games, Pan Pacific Championships, and the Commonwealth Games. Subjects gave written informed consent for medical surveillance as part of their national team medical support programme administered by the national governing body of the sport, Australian Swimming Inc.
Performance
Competition performance was assessed by the official international point score (IPS) system used by the international swimming federation (Fédération Internationale de Natation Amateur -FINA). The mean time of the eight fastest swims in history in each event is ascribed the value of 1000 points, with individual performances rated against this reference value. This system allows comparison of a given competitive performance by a male or female athlete in any of the sanctioned events (that is, freestyle, butterfly, backstroke, breast stroke, and individual medley). The scoring system is used by leading coaches and swimmers worldwide, and is accessible at http://www.swimnews.com/ranking/ ips.jhtml. During the taper period before the competitions we did not keep detailed training records for individual swimmers, but the competition performances were generally of a high standard for the Australian swimming team. In general, the course of the training programme followed the traditional decrease in training volume, reduced number of sessions, and development of swimming speed.
Monitoring illness
Symptoms of illness were monitored over a six week period including the taper phase and the major international competition in each calendar year. Swimmers free of symptoms during the study period were categorised as healthy, while those reporting illness (subject to the inclusion criteria) were categorised as ill. Symptoms were self reported on a seven day recall basis and confirmed by interview with the team physician and study investigators. The criteria for inclusion of a discrete episode of illness were that symptoms were reported for two or more consecutive days, or required modification of the training or competition programme on any given day. No severe episodes of illness were recorded and in every case the swimmer recovered sufficiently to compete in their selected event at the international competition. All swimmers were already preselected for their competitive events limiting the possibility of underreporting of illness for fear of non-selection in the international competition.
Symptoms were primarily mild to moderate self limiting respiratory illness in origin, although a small number of gastrointestinal and viral skin conditions were also reported.
The swimmers were asked to report any of the following symptoms: respiratory (sneezing, stuffy nose, runny nose, sore throat); lower respiratory (cough, sputum, chest congestion); generalised viral illness (aching joints, fever, and chills); gastrointestinal (nausea, vomiting, and diarrhoea); eye irritation (itchy, red, water, allergy); and skin conditions (spots, rashes, measles, skin infections). We cannot exclude the possibility that some of the upper respiratory symptoms may have been caused by allergic rhinitis but this is unlikely given that known polluted areas were not visited.
Statistical analysis
Competitive performance in the national and international swimming meets is presented as mean (between-subject SD). The degree of uncertainty in the estimate of the true (population) mean change in performance was expressed as 90% confidence intervals (90% CI). The unequal variances t statistic was used to analyse differences in the mean change in IPS points for competitive performances in swimmers with illness compared with their healthy counterparts. To determine whether the better swimmers had the same response to illness as the poorer swimmers we conducted an analysis of covariance for the effect of IPS in the nationals on change in IPS.
The uncertainty in the effect of illness on competitive swimming performance was calculated using the percent chance or likelihood that the true value of the effect was substantial (greater than the smallest practically important effect) and interpreted qualitatively. Thresholds for assigning the qualitative terms to chances of substantial effects were: ,1%, almost certainly not; ,5%, very unlikely; ,25%, unlikely or probably not; ,50%, possibly not; .50%, possibly; Values are mean (SD) with 90% confidence intervals (CI). Estimation of the magnitude of the smallest worthwhile change or effect in terms of international swimming performance was based on the methods outlined previously. 6 In brief, the smallest worthwhile change in performance for an elite athlete is approximately 0.5 of the within-athlete standard deviation in performance between competitions. 6 12 13 The within-athlete variation for international swimmers is approximately 0.8% of performance time.
14 To determine the magnitude of this value for the current study, we examined the IPS listings for the 2003 calendar year for all male and female freestyle events from the 50 m to the 1500 m. A difference in performance time equating to 0.4% (that is, 0.560.8%) at the internationally competitive level of 950 IPS was six points and we therefore assigned this value as the smallest worthwhile change.
To estimate the effect of illness on the performance of individual swimmers, we first estimated a standard deviation representing individual responses (the square root of the difference in the variances in the change scores in the illness and healthy groups). 15 We combined this standard deviation with the standard error of the mean effect of illness to derive the sampling distribution for a swimmer's true response to illness. Degrees of freedom for the distribution were computed via the Satterthwaite approximation. 16 Chances for beneficial, trivial, and harmful changes were estimated by assuming a smallest worthwhile change in the IPS of 6. Confidence limits for the estimates were derived by bootstrapping. The two primary outcomes of interest were: the likelihood that illness would reduce the chance of a given swimmer substantially improving their performance, and the likelihood that illness would increase the chance of a substantial decline in performance.
RESULTS
Characteristics of the sample
Over the three year study period illness was reported before 35% of international performances in male swimmers and before 38% of performances in female swimmers. For male and female swimmers combined there were 18 performances associated with illness (44% of total performances) in the first year of the study, 17 (35%) in the second, and 13 (30%) in the final year. Table 1 shows IPS at baseline (the national championships) for swimmers who were subsequently healthy or ill before the major international competition.
Mean response to illness
The mean effects of illness on the change in IPS between the national and international competitions are shown in table 2. Illness was associated with a trivial impairment of mean performance in the female swimmers and a small impairment in the male swimmers. These uncertainties can be expressed as chances of the true mean effect being beneficial/ trivial/harmful; the chances were 0%/40%/60% for the male swimmers and 9%/73%/18% for the female swimmers. Thus for male swimmers, illness is almost certainly not beneficial and possibly harmful, whereas for female swimmers illness is unlikely to be beneficial or harmful.
Individual response to illness
The IPS change scores for individuals plotted against their baseline (national) scores are shown in fig 1. All groups showed trends towards an inverse relation between baseline score and change score. The difference between the trends for the healthy and ill male swimmers implies that illness had a greater effect on slower swimmers; the healthy-ill difference in the IPS change score at a baseline score of 960 was 8.5 (90% CI, ¡8.5), whereas the difference for the fastest swimmers (baseline of 1030) was negligible.
The standard deviation of the change scores was greater for the ill swimmers than for the healthy swimmers (table 2), indicating that there were individual responses in the effects of illness on performance. Expressed as standard deviations, the individual responses were 12 points (90% CI, 25 to 17) and 10 points (213 to 19) for the male swimmers and female swimmers, respectively. These individual responses, combined with the uncertainty in the mean effect of illness, provided estimates of chances that being ill (relative to being healthy) would have a beneficial/trivial/harmful effect on performance of an individual (table 3). It appears that an individual male swimmer reporting illness had a threefold greater chance of his competitive performance being harmed than improved.
DISCUSSION
Given the limitations of relying solely on statistical significance to interpret the often subtle factors influencing international level sporting performance, 7 8 17 18 we calculated the likelihood that the true change in performance is greater than a predetermined smallest important or worthwhile change. 17 In female swimmers, the mean effects of illness on performance were trivial. The male swimmers with illness had a mean reduction of 7.0 points (equating to a time differential of , 0.5 s over a 200 m race) in the IPS rating compared with their healthy team mates, a magnitude that is slightly greater than the smallest worthwhile change of 6.0 points. The pertinent question is how likely is it that the true change for the population of international swimmers is greater than 26.0 points, given 90% confidence limits of 20.1 to 213.9. The chances of a true reduction in performance with illness were 60%, or odds of approximately 2 to 1. Hence for male swimmers, mild illness between competitions ''possibly'' results in a substantial decline in performance. Based on this study the advice to the coach or swimmer would be that ''the odds are only 2 to 1 or ,60% that illness experienced during the taper period will lead to a substantial decrease in performance.'' Trivial to small effects of illness are not surprising, considering that the athletes were well enough to compete. On the basis of these results, clinicians can reassure athletes that symptoms of mild illness during the final few weeks of a preparation do not necessarily lead to a substantial decline in subsequent performance.
Notwithstanding these trivial to small mean effects of illness on performance, the analysis of individual responses indicates that the mean effect does not characterise the effect in individual swimmers adequately. Indeed, the standard deviation representing individual responses, defined as the typical variation in the response to illness from individual to individual, was substantial in both male and female swimmers, though a larger sample size is needed to reduce its uncertainty. Importantly, this standard deviation is free from within-subject measurement error, as this source of error may have an appreciable bearing on the magnitude of the individual response to the predictor variable 18 -in this case the presence of illness. The individual responses analysis revealed that on average 32 of every 100 female swimmers and 17 of every 100 male swimmers may actually benefit from illness. This contrasts with the lower likelihoods for benefit based on the mean response. However, the substantial risk of harm for the individual underscores the responsibility of coaches, athletes, and team personnel for the implementation of practical and self management strategies. 19 20 These strategies include management of physical training loads, psychological stress, environmental conditions, dietary and self hygiene practices, and clinical considerations including treatment and prophylactic therapeutic intervention. 19 21 The apparently beneficial effect of mild illness for some individuals may be the result of a period of enforced rest during the taper period. Given the evidence of individual responses to illness in this investigation, future studies should focus on identifying the subject characteristics and other factors that predict them. This process would involve using these factors as covariates in the statistical analysis of predictor and outcome variables. Potential factors accounting for variation in the individual response to illness are likely to include the following: the severity, duration, and timing of illness; physical training loads; the presence of psychological stress; nutritional status; immune status; medical history and pre-existing medical conditions; and the degree of pathogen exposure. 3 19 The data showing a distribution of changes in performance from impaired to improved are consistent with the findings of an earlier study showing a range from 21.1% to +6.0% during the taper in swimmers before the 2000 Olympic Games. 22 One characteristic that did account for individual responses to a small extent was the ability of the athlete, as represented by the IPS in the national competitions. The analysis of covariance for the effect of IPS in the nationals on the change in IPS between competitions suggested that the effect of illness tended to be negligible for top male swimmers, with little effect of illness on the chances of female swimmers swimming better or worse. However, the difference between the trends for the healthy and ill male swimmers implies that illness had a greater effect on slower swimmers. It is unclear why this response was observed in the male but not the female swimmers. One possible explanation is that male swimmers suffering symptoms of illness may have had a tendency to give up, whereas their female counterparts maintained their effort irrespective of the underlying health status.
This study is the first to quantify individual responses to illness on sporting performance. Our method of expressing individual responses as chances of benefit and harm is closely related to the recent practice in clinical research of estimating the number needed to treat before one patient benefits (NNB) and the number needed to treat before one patient is harmed (NNH) 10 : chances of benefit and harm are simply 100/NNB and 100/NNH, respectively. We have found it easier to understand the implications for individuals when individual responses are expressed as chances of benefit and harm rather than as numbers needed to treat for benefit and harm.
We also advise strongly against combining beneficial and harmful outcomes into a single number needed to treat, as proposed by Guyatt and coworkers, 9 because it is important for everyone to understand the likelihood of positive and negative consequences of a condition or a treatment on health or performance.
In summary, the analysis of the mean responses suggested that mild illness had a trivial effect on the competitive performances of female swimmers, and a substantial though small harmful effect in male swimmers. Although these mean effects were trivial to small, the chances of harm for individuals were substantial, and team personnel should therefore be aware of the need to implement practical strategies for limiting the risk of illness. Given the relatively small sample size and the degree of uncertainty in the estimates provided in this study, further investigations are required to clarify the likelihood of mild, moderate, and severe illness impairing athletic performance. Studies examining the performance of athletes should consider both the mean effects and the individual responses to a treatment or intervention in terms of the likelihood of a beneficial, trivial, or harmful outcome. The findings of the present investigation should assist clinicians in framing their advice to athletes and coaches on the implications of illness on performance.
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